一项关于纤维肌痛严重程度对睡眠质量影响的研究,使用炎症标志物
Ruchi Singh1, Jyotsana Rai1, Akash Pathak1
1Department of Physiology, AIIMS Bhopal, Madhya Pradesh, India.
Bioinformation
|March 31, 2025
概括
纤维肌痛的严重程度与增加的疼痛,疲劳和CRP等炎症标志物相关. 纤维肌痛的睡眠质量差可能会使这些症状恶化,这表明睡眠管理是关键的治疗方法.
科学领域:
- 风湿病学和免疫学
- 疼痛医学 医学 疼痛医学
- 睡眠科学 睡眠科学
背景情况:
- 纤维肌痛综合征 (FMS) 的特点是普遍的疼痛,疲劳和睡眠障碍.
- 众所周知,睡眠不足会加剧FMS患者的炎症和疼痛.
- 由于FMS的睡眠障碍,炎症标志物可能会增加.
研究的目的:
- 调查纤维肌痛严重程度与C反应性蛋白 (CRP) 水平之间的关系.
- 探索FMS严重程度对睡眠质量和疼痛强度的影响.
- 为了确定睡眠质量是否影响FMS中的炎症标志物.
主要方法:
- 89名患有FMS的个体被评估了疾病严重程度,疼痛和睡眠质量.
- 血液样本分析了C-反应蛋白 (CRP) 和红细胞沉积率 (ESR) 以测量炎症.
- 统计分析被用来关联FMS严重程度,睡眠质量,疼痛和炎症标志物.
主要成果:
- 纤维肌痛严重程度的增加与较高的CRP和ESR水平有关.
- 较大的FMS严重程度与增加的疼痛强度和较差的睡眠质量相关.
- 在CRP水平和睡眠质量差之间发现了正相关性.
结论:
- 纤维肌痛的严重程度与炎症升高和疼痛和睡眠障碍恶化有关.
- 在FMS患者的睡眠质量差可能会导致CRP水平升高.
- 针对睡眠质量可能是管理FMS严重程度和症状的关键策略.
相关概念视频
Insufficient Sleep and Sleep Deprivation
121
Insufficient sleep refers to not getting the recommended amount of sleep for optimal functioning, even if it's just slightly less than needed. Sleep insufficiency may occur due to lifestyle choices, such as staying up late for social events or work, resulting in routinely getting less sleep than required. For example, consistently sleeping 6 hours when the body needs 7-9 hours can lead to cumulative effects on health and well-being.
Sleep deprivation is a more severe form of sleep loss...
Sleep deprivation is a more severe form of sleep loss...
121
Sedatives and Hypnotics Drugs: Miscellaneous Agents
132
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
132
Insomnia
77
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
77


